← back to search

James D. Berry

Buffalo State University · US
Area of research
Neurology · Plant Science
Research interest
Research interests include Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research, Irrigation Practices and Water Management, and Plant Physiology and Cultivation Studies.
h-index
56
citations
13,189
works
415
NIH funding
primary concept
Amyotrophic lateral sclerosis
email

Recent publications

Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trial.
2026cited by 1position: contributordoi
Skeletal Muscle Biomarkers of Amyotrophic Lateral Sclerosis: A Large-Scale, Multi-Cohort Proteomic Study.
2026cited by 1position: contributordoi
Bridging the gap: understanding participation barriers in ALS clinical trials through on-the-ground insights.
2026cited by 0position: contributordoi
The Amyotrophic Lateral Sclerosis House Call Program: A Single-Center Experience in the United States.
2026cited by 0position: contributordoi
TDP-43 loss induces cryptic polyadenylation in ALS/FTD
Nature Neuroscience 2025cited by 16position: middledoi
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis
JAMA Network Open 2025cited by 15position: middledoi
Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis
Nature 2025cited by 12position: middledoi
Skeletal Muscle Biomarkers of Amyotrophic Lateral Sclerosis: A Large‐Scale, Multi‐Cohort Proteomic Study
Annals of Neurology 2025cited by 3position: middledoi
Variability across versions of the self-administered ALSFRS-R: a review and call for harmonization
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2025cited by 3position: middledoi
Longer disease progression milestone-free time in people with amyotrophic lateral sclerosis treated versus not treated with intravenous edaravone: results from an administrative claims analysis.
2025cited by 2position: contributordoi
Listener effort measures clinically meaningful change of dysarthria in amyotrophic lateral sclerosis.
2025cited by 1position: contributordoi
A Preliminary Investigation of Acoustic Features for Remote Monitoring of Respiration in ALS.
2025cited by 1position: contributordoi
Cardiac Troponin T in Tofersen-Treated SOD1 ALS Patients: Beginning to Resolve the Catch-22 of Identifying Treatment Responsive Biomarkers in ALS Drug Development.
2025cited by 0position: contributordoi
Real-World Clinical Experience With Sodium Phenylbutyrate and Taurursodiol at a Single Amyotrophic Lateral Sclerosis Center in the United States.
2025cited by 0position: contributordoi
What can vowel acoustics reveal about the communicative participation of people living with ALS?
2025cited by 0position: contributordoi
Analytical and clinical validation of step counting method in people living with amyotrophic lateral sclerosis
2025cited by 0position: contributordoi
Short prescribed exercises can quantify upper limb functioning in neurodegenerative disease
2025cited by 0position: contributordoi
Design considerations for C9orf72 disease prevention trials.
2025cited by 0position: contributordoi
A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD
Nature Medicine 2024cited by 137position: middledoi
A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD.
2024cited by 114position: contributordoi
The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology
Nature Reviews Neurology 2024cited by 39position: middledoi
The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2024cited by 19position: middledoi
Disease related changes in ATAC-seq of iPSC-derived motor neuron lines from ALS patients and controls
Nature Communications 2024cited by 12position: middledoi
Access for ALL in ALS: A large-scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis.
2024cited by 7position: contributordoi
Author Correction: TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A
Nature 2024cited by 4position: middledoi
Identifying amyotrophic lateral sclerosis through interactions with an internet search engine.
2024cited by 3position: contributordoi
Author Correction: A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD.
2024cited by 3position: contributordoi
Listener effort quantifies clinically meaningful progression of dysarthria in people living with amyotrophic lateral sclerosis
2024cited by 3position: contributordoi
The relationship of rate and pause features to the communicative participation of people living with ALS.
2024cited by 1position: contributordoi
Wearable device and smartphone data quantify ALS progression and may provide novel outcome measures.
2023cited by 39position: contributordoi

Grants

MRI: Acquisition of a Confocal Microscopy System for Research and Education
NSF0923133$482,3142009–2012PIRePORTER
Post-transcriptional control of C4 RbcS Gene Expression in Flaveria bidentis
NSF0544234$545,5282006–2010PIRePORTER
Post-transcriptional Control of rbcL Gene Expression in the C4 dicots Amaranth and Flaveria Bidentis
NSF0110411$345,0012001–2006PIRePORTER
Translational Control of RuBPCase Gene Expression
NSF9728547$275,8001998–2002PIRePORTER
U.S.-Australia Cooperative Research: Analysis of Transcriptional & Post-Transcription Gene Constructs in Transgenic C4 Plants
NSF9724775$35,2801998–2000PIRePORTER
Translational Control of RuBPCase Gene Expression in Amaranth
NSF9316806$282,0001994–1998PIRePORTER

Frequent collaborators

· 30 papers (2021–2026)Sabrina Paganoni · Harvard University14 papers (2020–2026)Merit Cudkowicz · Harvard University13 papers (2012–2025)Katherine M. Burke · Massachusetts General Hospital12 papers (2021–2025) · 12 papers (2021–2026)Jonathan D. Glass · Emory University9 papers (2012–2024)Jukka-Pekka Onnela · Harvard TH Chan School of Public Health6 papers (2021–2025)Zoe Scheier · Philadelphia College of Osteopathic Medicine6 papers (2021–2025)Kathryn P Connaghan · Publons5 papers (2021–2025)Jeremy M. Shefner · Mayo Clinic in Florida5 papers (2013–2024)Robert H. Brown · Harvard University5 papers (2014–2022)Angela Genge · Valve (United States)5 papers (2019–2025)Michael Benatar · University of Miami5 papers (2015–2025)Jeffrey D. Rothstein · German Center for Neurodegenerative Diseases4 papers (2013–2022)Robert G. Miller · Universidade de Brasília4 papers (2019–2022)Jinsy Andrews · Valve (United States)4 papers (2019–2024)Hiroshi Mitsumoto · Columbia University Irving Medical Center4 papers (2019–2022)Robert H. Baloh · Cedars-Sinai Medical Center4 papers (2019–2021)Merit Cudkowicz · Assistance Publique – Hôpitaux de Paris4 papers (2022–2026)Marcin Straczkiewicz · Harvard University Press4 papers (2022–2025)